HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minoxidil Spray Applicator Child-Resistant Features Required By Late 1999

This article was originally published in The Rose Sheet

Executive Summary

OTC minoxidil metered finger mechanical sprayer applicators and extender attachments are required to include child-resistant features by November 1999 under a Consumer Product Safety Commission final rule published in the Federal Register Nov. 16.

You may also be interested in...



Oral OTC switches

Consumer Product Safety Commission is considering a staff proposal to require that all oral Rx-to-OTC switch drugs be packaged in child-resistant containers, CPSC Poison Prevention Project Manager Suzanne Barone, PhD, announces at a meeting in Bethesda, Md. June 7. Currently, the Poison Prevention Packaging Act calls for child-resistant packaging (CRP) for most oral Rx drugs, but not for products that switch to OTC unless it is specifically requested by the commission. CPSC already requires CRP for hair regrowth ingredient minoxidil (1"The Rose Sheet" Nov. 23, 1998, p. 8). The proposed rule would not cover other types of switches, such as topical preparations or transdermal patches

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel